Virpax Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -3,390 | -1,913 | -3,458 | -3,302 |
EBIT | -3,394 | -1,924 | -3,477 | -6,604 |
Net Income | -3,390 | -2,006 | -3,450 | -3,220 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -2,870 | -4,469 | -1,643 | -7,729 |
Cash | 1,513 | 17 | 1,870 | 1,866 |
Basic Shares | 4,254 | 4,657 | 1,977 | 1,171 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -12,079,935 | -2,249 | -21,650 | -11,963 |
EBIT | -15,689 | -15,189 | -39,995 | -23,988 |
Net Income | -12,067,225 | -15,189 | -21,456 | -12,148 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -16,712,900 | -9,853 | -17,846 | -14,542 |
Cash | 1,513 | 9,141 | 18,995 | 36,841 |
Basic Shares | 4,254 | 1,171 | 1,171 | 1,171 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$10.76 |
2024-06-30 | -$1.75 |
2024-03-31 | -$2.74 |
2023-12-31 | -$3.90 |
